Clinical Trial Update: A Phase IV Study of Cipro XR in Uncomplicated UTI [Phase 4]

View source ↗

Summary

A Phase IV study evaluating Cipro XR (ciprofloxacin extended-release) for uncomplicated urinary tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Cipro XR (ciprofloxacin)

Snippet

Sponsor: Bayer | Conditions: Urinary Tract Infections | Phase 4 | Status: COMPLETED